Similar Articles
911 Genetic alterations in hepatocellular carcinoma: An update
912 Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature
913 Local ablative treatments for hepatocellular carcinoma: An updated review
914 Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
915 Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma
916 Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention
917 Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival
918 Lycopene modulates cellular proliferation, glycolysis and hepatic ultrastructure during hepatocellular carcinoma
919 Polymorphisms of folate metabolism genes in patients with cirrhosis and hepatocellular carcinoma
920 Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA